PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Zealand University Hospital, Roskilde, Denmark. Electronic address: hans.hasselbalch@gmail.com.\', \'Department of Hematology, Zealand University Hospital, Roskilde, Denmark.\', \'Department of Research, Production, Innovation, Region Zealand, Denmark; Department of Pathology, Harvard Medical School, Boston, MA, United States; Department of Laboratory Medicine, Boston Children\'s Hospital, Boston, MA, United States.\', \'Department of Anestesiology and Intensive Care Unit, Zealand University Hospital, Roskilde, Denmark.\', \'Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1359-6101(21)00033-210.1016/j.cytogfr.2021.03.006
?:hasPublicationType
?:journal
  • Cytokine & growth factor reviews
is ?:pmid of
?:pmid
?:pmid
  • 33992887
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all